Insider Transactions in Q3 2021 at Becton Dickinson & CO (BDX)
Insider Transaction List (Q3 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 08
2021
|
Rebecca W Rimel Director |
SELL
Open market or private sale
|
Direct |
500
-4.5%
|
$130,000
$260.0 P/Share
|
Sep 08
2021
|
David Hickey EVP & President, Life Sciences |
SELL
Open market or private sale
|
Direct |
500
-12.24%
|
$130,000
$260.0 P/Share
|
Sep 08
2021
|
Thomas J Spoerel SVPController & Chief Acct Off |
SELL
Open market or private sale
|
Direct |
267
-20.78%
|
$69,420
$260.0 P/Share
|
Sep 07
2021
|
Christopher Del Orefice EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,359
+50.0%
|
-
|
Sep 04
2021
|
David Hickey EVP & President, Life Sciences |
SELL
Payment of exercise price or tax liability
|
Direct |
268
-6.16%
|
-
|
Sep 03
2021
|
James C Lim Executive Vice President |
SELL
Open market or private sale
|
Direct |
6,956
-26.03%
|
$1,787,692
$257.44 P/Share
|
Sep 03
2021
|
James C Lim Executive Vice President |
SELL
Sale (or disposition) back to the issuer
|
Direct |
7,628
-22.21%
|
$1,960,396
$257.44 P/Share
|
Sep 03
2021
|
James C Lim Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
14,584
+29.8%
|
$1,954,256
$134.73 P/Share
|
Sep 03
2021
|
Rebecca W Rimel Director |
SELL
Open market or private sale
|
Direct |
500
-4.3%
|
$128,500
$257.1 P/Share
|
Sep 02
2021
|
Rebecca W Rimel Director |
SELL
Open market or private sale
|
Direct |
244
-2.06%
|
$61,976
$254.0 P/Share
|
Aug 30
2021
|
Rebecca W Rimel Director |
SELL
Open market or private sale
|
Direct |
207
-1.72%
|
$52,164
$252.0 P/Share
|
Aug 18
2021
|
Claire Fraser Director |
SELL
Open market or private sale
|
Direct |
387
-1.88%
|
$97,137
$251.58 P/Share
|
Aug 17
2021
|
Rebecca W Rimel Director |
SELL
Open market or private sale
|
Direct |
207
-1.69%
|
$52,164
$252.0 P/Share
|
Aug 06
2021
|
Thomas J Spoerel SVPController & Chief Acct Off |
SELL
Open market or private sale
|
Direct |
266
-17.15%
|
$64,372
$242.3 P/Share
|